Bank of New York Mellon’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bank of New York Mellon’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-103,636	Closed	-$7.77M	–	4474
2015 Q3	$7.77M	Sell	103,636 -51,598	-33%	-$3.85M	﹤0.01%	1998
2015 Q2	$11.7M	Sell	155,234 -463,798	-75%	-$24.9M	﹤0.01%	1876
2015 Q1	$31M	Buy	619,032 +318,848	+106%	+$13.4M	0.01%	1186
2014 Q4	$10.4M	Sell	300,184 -1,088	-0.4%	-$38K	﹤0.01%	1887
2014 Q3	$9.87M	Buy	301,272 +33,731	+13%	+$1.19M	﹤0.01%	1903
2014 Q2	$10.3M	Buy	267,541 +45,890	+21%	+$1.6M	﹤0.01%	1915
2014 Q1	$8.81M	Buy	221,651 +26,181	+13%	+$1.17M	﹤0.01%	1978
2013 Q4	$7.3M	Buy	195,470 +104,859	+116%	+$4.35M	﹤0.01%	2065
2013 Q3	$4.13M	Sell	90,611 -4,926	-5%	-$147K	﹤0.01%	2348
2013 Q2	$2.58M	Buy	+95,537	New	+$2.19M	﹤0.01%	2623

Bank of New York Mellon's KYTH Position: Q4 2015 in Review

Bank of New York Mellon sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 103,636 shares — an estimated $7.77M sold.

Bank of New York Mellon first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $31M in Q1 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Bank of New York Mellon reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Bank of New York Mellon sold 103,636 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $7.77M.
Bank of New York Mellon first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
Bank of New York Mellon's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $31M in Q1 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Bank of New York Mellon's 13F filing for Q4 2015, filed 12 Feb 2016.